Zydus Cadila Gets Usfda Nod To Market Generic Cancer Drug In Us

Zydus Cadila Gets Usfda Nod To Market Generic Cancer Drug In Us

By, Admin 22 November 2021

Drug Firm Zydus Cadila OnSaturday Said It Has ReceivedApproval From The Us HealthRegulator To Market DecitabineInjection, Used To Treat CertainTypes Of Cancers, In TheAmerican Market. The CompanyHas Received Final Approval FromThe Us Food And DrugAdministration (Usfda) ToDecitabine For Injection In TheStrength Of 50 Mg/Vial Single-Https://Health.Economictimes.Indiatimes.Com/News/Pharma/Zydus-Cadila-Gets-Usfda-Nod-To-Market-Generic-Cancer-Drug-In-Us/87818957 2/9Importance Of FinancialPlanning For HealthcareIn The Light Of TheNo Scientific Evidence InCountry Underlines NeedFor Covid-19 BoosterSun Pharma Recalls Over1.10 Lakh Bottles OfGeneric Drug In UsCovaxin Offers ProtectionAgainst Multiple Variants:StudyPharma Zydus Cadila Usfda Us Pharma Firms Health News Generic DrugsDose Vial, Zydus Cadila Said In A Statement.Decitabine Is Used To Treat Myelodysplastic Syndromes, Certain Types Of Blood OrBone Marrow Cancer.The Drug Will Be Manufactured At The Group'S Injectables Manufacturing Facility, TheDrug Maker Said.The Zydus Group Now Has 326 Approvals And Has So Far Filed Over 400Abbreviated New Drug Applications (Andas) Since The Commencement Of The FilingProcess In 2003-04, It Added.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!